2026 Research Grants
We are so happy to announce that Gabrielle’s Angel Foundation’s Medical Advisory Board approved the funding of 7 new Medical Research Awards, totaling...
Your support of Gabrielle’s Angel Foundation allows us to push the boundaries of what is scientifically possible for those living with blood cancer. Meet the dedicated research scientists whose cutting-edge ideas are giving patients reason to hope and hear all about their latest breakthroughs below!
The 2025 $15,000 Grantees
In addition to the 8 early career scientists who received grants of $225,000 each in 2025, Gabrielle’s Angel Foundation’s Medical Advisory Board also awarded ten grants of $15,000 each. The...
New study reveals how disrupted DNA navigation leads to impaired red blood cell development in myelodysplastic syndrome
Researchers at Columbia University, including 2025 Gabrielle’s Angels Grantee Dr. Aaron Viny, have uncovered a key mechanism that helps explain how certain blood cancers develop. Their study...
BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation
Gabrielle’s Angel Foundation grantee Jaebok Choi recently published a paper in Molecules. This study tested a new experimental drug called BI-5756 in laboratory and mouse models of bone marrow...
Music Therapy Versus Cognitive Behavioral Therapy via Telehealth for Anxiety in Cancer Survivors: A Randomized Clinical Trial
Gabrielle’s Angels grantee Dr. Kevin Liou from MSKCC recently published findings from the clinical trial our grant helped support in the Journal of Clinical Oncology. This study tested whether...
Dana-Farber Researchers Discover How Major Nuclear Protein Complexes Control Specialized Gene Regulation in Cancer and Beyond
Gabrielle’s Angels grantee Dr. Cigall Kadoch at the Dana-Farber Cancer Institute was part of a team of researchers who discovered a new part of an important gene-regulating machine in our...
Ross Levine, MD, Named Chief Scientific Officer of Memorial Sloan Kettering Cancer Center
Former Gabrielle’s Angel Foundation Grantee Dr. Ross Levine has been named the Chief Scientific Officer of Memorial Sloan Kettering Cancer Center. We first funded Dr. Levine with a Medical...
Grantee Dr. Anthony Letai Has Been Appointed the 18th Director of the National Cancer Institute
We are thrilled to share that Dr. Anthony Letai, a 2007 Gabrielle’s Angel Foundation grantee, has been appointed Director of the National Cancer Institute. We supported Dr. Letai early in his...
Grantee Dr. Omar Abdel-Wahab from MSKCC Elected to the Prestigious National Academy of Medicine
Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at...
2025 Research Grants
We are proud to announce that Gabrielle’s Angel Foundation’s Medical Advisory Board recently approved the funding for 8 new grants of $225,000 each, totaling $1.8 million! We are...
Scientists and Doctors Reveal How Genes are Mapping Cures for Cancer
A recently published article in Newsweek discusses the groundbreaking advancements in genetic sequencing that are transforming cancer treatment. It highlights how technologies like whole genome...
Dr Ruella on Improving Access to CAR T-Cell Therapy for Minority Populations in Multiple Myeloma
Marco Ruella, MD, Gabrielle’s Angels grantee in 2014 and 2017 (Medical Advisory Board discretionary funding) and 2019 (Medical Research Award), assistant professor, medicine...